Efeitos clínico, comportamental e antinociceptivo da crotalfina em equinos
Carregando...
Data
2016-04-01
Autores
Guirro, Erica Cristina Bueno do Prado
Perotta, João Henrique
Paula, Márcio de
Cury, Yara
Valadão, Carlos Augusto Araújo [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Crotalphine is a novel analgesic peptide that acts on kappa opioid and delta receptors, causing powerful analgesia in rats submitted to inflammatory, neuropathic or oncologic models of pain. This study evaluated clinical, behavioral and antinociceptive effects caused by crotalphine in horses, employing 18 Arabian horses and it was divided in three phases. In Phase I, “clinical and behavioral effects”, crotalphine did not change the latency to urinate and defecate; did not modify the values of cardiac or respiratory rates, intestinal motility and rectal temperature; and did not cause significant ataxia, head, eye and lip ptosis. In Phase II, “antinociceptive effect on intact skin at scapular or ischial region”, crotalphine did not cause significant analgesia. In Phase III, “antinociceptive effect on incised skin at scapular or ischial region”, crotalphine promoted effective antinociceptive effects for six hours and inhibited hyperalgesia state for three days in the ischial region of horses submitted to incisional model of inflammatory pain, but crotalphine did not evoke relevant analgesic effect on the scapular region. Concluding, intravenous injection of a single dose of crotalphine (3.8ngkg-1) did not cause important clinical or behavioral changes and promotes antinociceptive effect on incised ischial region for seven days in horses. Moreover, crotalphine did not evoke relevant anti nociceptive effect on the scapular region or in intact skin of horses.
Descrição
Palavras-chave
Crotalphine, Horses, Kappa, Nociception, Opioids
Como citar
Ciencia Rural, v. 46, n. 4, p. 694-699, 2016.